Meredith Wealth Planning’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Sell
348
-7
-2% -$7.15K 0.1% 55
2026
Q1
$327K Sell
355
-1
-0.3% -$1.01K 0.09% 56
2025
Q4
$382K Buy
356
+1
+0.3% +$956 0.11% 49
2025
Q3
$271K Sell
355
-5
-1% -$3.72K 0.09% 57
2025
Q2
$281K Sell
360
-3
-0.8% -$2.33K 0.1% 52
2025
Q1
$300K Hold
363
0.13% 42
2024
Q4
$280K Hold
363
0.12% 45
2024
Q3
$321K Sell
363
-8
-2% -$7.19K 0.15% 38
2024
Q2
$336K Buy
371
+1
+0.3% +$800 0.18% 35
2024
Q1
$288K Sell
370
-36
-9% -$25.6K 0.16% 35
2023
Q4
$237K Hold
406
0.15% 40
2023
Q3
$218K Buy
+406
New +$209K 0.16% 39

Other funds holding LLY

Meredith Wealth Planning's LLY Position: Q2 2026 in Review

Meredith Wealth Planning reduced its Eli Lilly (LLY) stake by 2% in Q2 2026, selling an estimated $7.15K and leaving 348 shares worth $418K. The position accounts for 0.1% of the portfolio, ranked #55.

Meredith Wealth Planning first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Meredith Wealth Planning held 348 shares of Eli Lilly worth $418K as of Q2 2026.
  • Meredith Wealth Planning sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.1% of Meredith Wealth Planning's portfolio in Q2 2026, its #55 holding.
  • Meredith Wealth Planning first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Meredith Wealth Planning's 13F filing for Q2 2026, filed 24 Jul 2026.